Cargando…

Osteosarcoma follow-up: chest X-ray or computed tomography?

BACKGROUND: In patients with relapsed osteosarcoma, the surgical excision of all metastases, defined as second complete remission (CR-2), is the factor that mainly influences post-relapse survival (PRS). Currently a validated follow-up policy for osteosarcoma is not available, both chest X-ray and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paioli, Anna, Rocca, Michele, Cevolani, Luca, Rimondi, Eugenio, Vanel, Daniel, Palmerini, Emanuela, Cesari, Marilena, Longhi, Alessandra, Eraldo, Abate Massimo, Marchesi, Emanuela, Picci, Piero, Ferrari, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307808/ https://www.ncbi.nlm.nih.gov/pubmed/28228934 http://dx.doi.org/10.1186/s13569-017-0067-5

Ejemplares similares

Erratum to: Osteosarcoma follow-up: chest X-ray or computed tomography?
por: Paioli, Anna, et al.
Publicado: (2017)

High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series
por: Palmerini, Emanuela, et al.
Publicado: (2020)

High-grade focal areas in low-grade central osteosarcoma: high-grade or still low-grade osteosarcoma?
por: Righi, Alberto, et al.
Publicado: (2015)

The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas
por: Palmerini, Emanuela, et al.
Publicado: (2016)

Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone
por: Palmerini, E., et al.
Publicado: (2016)

Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results
por: Palmerini, Emanuela, et al.
Publicado: (2018)

Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1
por: Palmerini, Emanuela, et al.
Publicado: (2017)

Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans
por: Palmerini, Emanuela, et al.
Publicado: (2012)

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
por: Boye, Kjetil, et al.
Publicado: (2021)

Phase 2 study for nonmetastatic extremity high‐grade osteosarcoma in pediatric and adolescent and young adult patients with a risk‐adapted strategy based on ABCB1/P‐glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS‐2)
por: Palmerini, Emanuela, et al.
Publicado: (2022)

Lung metastasectomy for osteosarcoma in children, adolescents, and young adults: proof of permanent cure
por: Pastorino, Ugo, et al.
Publicado: (2021)

Malignancy in Giant Cell Tumor of Bone: A Review of the Literature
por: Palmerini, Emanuela, et al.
Publicado: (2019)

Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study
por: Palmerini, Emanuela, et al.
Publicado: (2022)

Osteosarcoma (Osteogenic sarcoma)
por: Picci, Piero
Publicado: (2007)

Long-Term Follow-up of a Randomized Study of Oral Etoposide versus Viscum album Fermentatum Pini as Maintenance Therapy in Osteosarcoma Patients in Complete Surgical Remission after Second Relapse
por: Longhi, Alessandra, et al.
Publicado: (2020)

Chondroblastoma’s Lung Metastases Treated with Denosumab in Pediatric Patient
por: Focaccia, Marco, et al.
Publicado: (2021)

NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case report
por: Palmerini, Emanuela, et al.
Publicado: (2023)

Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study
por: Abate, Massimo E., et al.
Publicado: (2021)

Solitary bone lesions: which ones to worry about?
por: Vanel, Daniel, et al.
Publicado: (2012)

Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?
por: Palmerini, Emanuela, et al.
Publicado: (2015)

Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study
por: Asaftei, Sebastian Dorin, et al.
Publicado: (2021)

Difficulty distinguishing benign notochordal cell tumor from chordoma further suggests a link between them
por: Kreshak, Jennifer, et al.
Publicado: (2014)

CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338
por: Pollino, Serena, et al.
Publicado: (2019)

Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
por: Palmerini, Emanuela, et al.
Publicado: (2021)

Comparison of the Outcome of Conventional Osteosarcoma at Two Specialist International Orthopaedic Oncology Centres
por: Ford, Samuel, et al.
Publicado: (2004)

Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells
por: Vella, Serena, et al.
Publicado: (2016)

Imaging of hibernomas: A retrospective study on twelve cases
por: Papathanassiou, Zafiria G, et al.
Publicado: (2011)

Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma
por: Hattinger, Claudia M., et al.
Publicado: (2016)

The incidental skeletal lesion: ignore or explore?
por: Vanel, D., et al.
Publicado: (2009)

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience
por: Setola, Elisabetta, et al.
Publicado: (2023)

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group
por: Palmerini, Emanuela, et al.
Publicado: (2021)

Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed
por: Ferrari, Stefano, et al.
Publicado: (2013)

A special jubilee: 100 fake osteosarcoma articles
por: Bielack, S.S., et al.
Publicado: (2021)

Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS)
por: Palmerini, Emanuela, et al.
Publicado: (2020)

Preclinical Effectiveness of Selective Inhibitor of IRS-1/2 NT157 in Osteosarcoma Cell Lines
por: Garofalo, Cecilia, et al.
Publicado: (2015)

How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience
por: Marchesi, Emanuela, et al.
Publicado: (2017)

COVID-19 Recognition Using Ensemble-CNNs in Two New Chest X-ray Databases
por: Vantaggiato, Edoardo, et al.
Publicado: (2021)

Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
por: Barnes, David J., et al.
Publicado: (2022)

Solitary fibrous tumors of the soft tissues: imaging features with histopathologic correlations
por: Papathanassiou, Zafaria G, et al.
Publicado: (2013)

Intraosseous papillary intralymphatic angioendothelioma (PILA): one new case and review of the literature
por: Gambarotti, Marco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pdtmcokconll066gns4h6hu415